🔴 10x Genomics is trading 4.4% down today amid broad technology and risk-asset selling

10x Genomics is trading 4.4% down at $65.57 as broad technology and risk-asset selling pressured the market on September 14, 2026.

• The Nasdaq Composite is down 0.95% and the S&P 500 is down 0.76%, amid AI-related weakness, higher oil prices, and uncertainty ahead of the Federal Reserve meeting.
• A reported September 9 CFO share sale adds company-specific overhang, but no direct fresh negative announcement was identified.